US Stock MarketDetailed Quotes

LXRX Lexicon Pharmaceuticals

Watchlist
  • 1.700
  • 0.0000.00%
Close May 31 16:00 ET
  • 1.700
  • 0.0000.00%
Post 17:24 ET
614.54MMarket Cap-2048P/E (TTM)

Lexicon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
4,608.33%1.13M
766.19%1.2M
2,407.14%702K
315.38%162K
805.71%317K
-35.14%24K
-53.36%139K
100.00%28K
69.57%39K
-85.04%35K
Operating revenue
4,608.33%1.13M
766.19%1.2M
2,407.14%702K
315.38%162K
805.71%317K
-35.14%24K
-53.36%139K
100.00%28K
69.57%39K
-85.04%35K
Cost of revenue
31K
85K
70K
7K
8K
0
0
0
0
0
Gross profit
4,479.17%1.1M
705.04%1.12M
2,157.14%632K
297.44%155K
782.86%309K
24K
-53.36%139K
28K
39K
35K
Operating expense
48.98%46.43M
71.33%172.87M
56.30%47.37M
115.21%49.79M
85.30%44.55M
33.09%31.17M
15.46%100.9M
19.58%30.31M
0.65%23.13M
32.15%24.04M
Selling and administrative expenses
67.50%32.06M
137.05%113.98M
99.69%32.61M
156.25%32.23M
180.82%30.01M
125.42%19.14M
48.67%48.08M
84.59%16.33M
72.22%12.58M
34.65%10.69M
-General and administrative expense
67.50%32.06M
----
----
156.25%32.23M
180.82%30.01M
125.42%19.14M
----
----
72.22%12.58M
--10.69M
Research and development costs
19.51%14.37M
11.49%58.89M
5.62%14.76M
66.32%17.56M
8.87%14.54M
-19.43%12.03M
-4.05%52.82M
-15.28%13.98M
-32.68%10.56M
30.21%13.36M
Operating profit
-45.57%-45.33M
-70.45%-171.75M
-54.36%-46.74M
-114.90%-49.63M
-84.28%-44.24M
-33.20%-31.14M
-15.70%-100.76M
-19.53%-30.28M
-0.58%-23.1M
-33.68%-24.01M
Net non-operating interest income expense
-286.87%-3.06M
-353.46%-5.37M
-1,297.69%-3.02M
-206.16%-894K
-14.48%-664K
-725.00%-792K
-77.25%-1.18M
23.13%-216K
-82.50%-292K
-437.04%-580K
Non-operating interest income
83.09%1.88M
384.46%7.73M
170.80%2.4M
425.35%3.01M
953.66%1.3M
7,250.00%1.03M
1,091.04%1.6M
6,235.71%887K
5,100.00%572K
101.64%123K
Non-operating interest expense
171.72%4.95M
371.26%13.1M
391.48%5.42M
351.27%3.9M
178.81%1.96M
1,555.45%1.82M
246.63%2.78M
273.90%1.1M
405.26%864K
315.98%703K
Other net income (expense)
Income before tax
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
-1.15%-23.39M
-36.09%-24.59M
Income tax
Net income
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
-1.15%-23.39M
-36.09%-24.59M
Net income continuous Operations
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
-1.15%-23.39M
-36.09%-24.59M
Minority interest income
Net income attributable to the parent company
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
-1.15%-23.39M
-36.09%-24.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
-1.15%-23.39M
-36.09%-24.59M
Basic earnings per share
-17.65%-0.2
-29.03%-0.8
-25.00%-0.2
-61.54%-0.21
-37.50%-0.22
-6.25%-0.17
-3.33%-0.62
5.88%-0.16
18.75%-0.13
-23.08%-0.16
Diluted earnings per share
-17.65%-0.2
-29.03%-0.8
-25.00%-0.2
-61.54%-0.21
-37.50%-0.22
-6.25%-0.17
-3.33%-0.62
5.88%-0.16
18.75%-0.13
-23.08%-0.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 4,608.33%1.13M766.19%1.2M2,407.14%702K315.38%162K805.71%317K-35.14%24K-53.36%139K100.00%28K69.57%39K-85.04%35K
Operating revenue 4,608.33%1.13M766.19%1.2M2,407.14%702K315.38%162K805.71%317K-35.14%24K-53.36%139K100.00%28K69.57%39K-85.04%35K
Cost of revenue 31K85K70K7K8K00000
Gross profit 4,479.17%1.1M705.04%1.12M2,157.14%632K297.44%155K782.86%309K24K-53.36%139K28K39K35K
Operating expense 48.98%46.43M71.33%172.87M56.30%47.37M115.21%49.79M85.30%44.55M33.09%31.17M15.46%100.9M19.58%30.31M0.65%23.13M32.15%24.04M
Selling and administrative expenses 67.50%32.06M137.05%113.98M99.69%32.61M156.25%32.23M180.82%30.01M125.42%19.14M48.67%48.08M84.59%16.33M72.22%12.58M34.65%10.69M
-General and administrative expense 67.50%32.06M--------156.25%32.23M180.82%30.01M125.42%19.14M--------72.22%12.58M--10.69M
Research and development costs 19.51%14.37M11.49%58.89M5.62%14.76M66.32%17.56M8.87%14.54M-19.43%12.03M-4.05%52.82M-15.28%13.98M-32.68%10.56M30.21%13.36M
Operating profit -45.57%-45.33M-70.45%-171.75M-54.36%-46.74M-114.90%-49.63M-84.28%-44.24M-33.20%-31.14M-15.70%-100.76M-19.53%-30.28M-0.58%-23.1M-33.68%-24.01M
Net non-operating interest income expense -286.87%-3.06M-353.46%-5.37M-1,297.69%-3.02M-206.16%-894K-14.48%-664K-725.00%-792K-77.25%-1.18M23.13%-216K-82.50%-292K-437.04%-580K
Non-operating interest income 83.09%1.88M384.46%7.73M170.80%2.4M425.35%3.01M953.66%1.3M7,250.00%1.03M1,091.04%1.6M6,235.71%887K5,100.00%572K101.64%123K
Non-operating interest expense 171.72%4.95M371.26%13.1M391.48%5.42M351.27%3.9M178.81%1.96M1,555.45%1.82M246.63%2.78M273.90%1.1M405.26%864K315.98%703K
Other net income (expense)
Income before tax -51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M-1.15%-23.39M-36.09%-24.59M
Income tax
Net income -51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M-1.15%-23.39M-36.09%-24.59M
Net income continuous Operations -51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M-1.15%-23.39M-36.09%-24.59M
Minority interest income
Net income attributable to the parent company -51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M-1.15%-23.39M-36.09%-24.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M-1.15%-23.39M-36.09%-24.59M
Basic earnings per share -17.65%-0.2-29.03%-0.8-25.00%-0.2-61.54%-0.21-37.50%-0.22-6.25%-0.17-3.33%-0.625.88%-0.1618.75%-0.13-23.08%-0.16
Diluted earnings per share -17.65%-0.2-29.03%-0.8-25.00%-0.2-61.54%-0.21-37.50%-0.22-6.25%-0.17-3.33%-0.625.88%-0.1618.75%-0.13-23.08%-0.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg